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Abstract
Lymphedema related to lymphatic filariasis (LF) is a disabling condition that commonly manifests in adolescence. Fifty-three
adolescents, 25 LF infected and 28 LF non-infected, in age and sex-matched groups, using the Binax ICT rapid card test for
filarial antigen were recruited to the study. None of the participants had overt signs of lymphedema. Lymphedema
assessment measures were used to assess lower limb tissue compressibility (tonometry), limb circumference (tape measure),
intra- and extra-cellular fluid distribution (bioimpedance) and joint range of motion (goniometry). The mean tonometric
measurements from the left, right, and dominant posterior thighs were significantly larger in participants with LF compared
to participants who had tested negative for LF (p = 0.005, p = 0.004, and p= 0.003, respectively) indicating increased tissue
compressibility in those adolescents with LF. ROC curve analysis to define optimal cut-off of the tonometry measurements
indicated that at 3.5, sensitivity of this potential screening test is 100% (95%-CI = 86.3%, 100%) and specificity is 21.4% (95%-
CI = 8.3%, 41.0%). It is proposed that this cut-off can be used to indicate tissue change characteristic of LF in an at-risk
population of PNG adolescents. Further longitudinal research is required to establish if all those with tissue change
subsequently develop lymphedema. However, thigh tonometry to identify early tissue change in LF positive adolescents
may enable early intervention to minimize progression of lymphedema and prioritization of limited resources to those at
greatest risk of developing lifetime morbidity.
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Introduction
The mosquito-borne parasitic disease lymphatic filariasis (LF) is
endemic in around 81 tropical countries, has a global burden of
around 120 million cases, and is classified by the World Health
organization as the second most common cause of long term
disability after mental illness [1]. Three species of filarial parasites
cause LF. Wuchereria bancrofti, the cause of Bancroftian filariasis,
accounts for 90% of the cases worldwide. Brugian filariasis is
caused by Brugia malayi, which is found in eastern Asia, and Brugia
timori, which is confined to Timor and adjacent islands. All three
species cause similar lymphatic disease but only Bancroftian
filariasis causes hydrocele and all are controlled and treated by the
same methods [2].
LF has a wide clinical spectrum ranging from debilitating acute
bacterial dermatolymphgangioadenitis (ADLA) attacks, covert
lymphatic and renal disease, and various degrees of lymphedema,
to the terrible disfiguring, and often socially ostracizing, chronic
manifestations of hydrocele and elephantiasis [3].
A global program to eliminate LF as a public health problem was
introduced in 2002 [1,3]. It is based upon two ‘‘pillars.’’ Pillar one is
the interruption of transmission by the use of community-wide
preventative chemotherapy (PCT). This used to be called ‘‘mass
drug administration’’, MDA. The second pillar is the alleviation of
suffering in those who already have chronic manifestations of the
disease.
Over time filarial infection can lead to the development of
chronic lymphedema. Infection often occurs in childhood but the
obvious clinical effects of the disease such as filarial lymphedema
or hydrocele may not occur until they reach adolescence [4].
Shenoy et al [5,6] have shown covert abnormalities in the
lymphatics with lymphoscintigraphy and worm nests by Doppler
ultrasonography in B.malayi LF-infected adolescents as young as
three years. Importantly, it has also been shown that these early
lymphatic changes can be reversed by rug administration [7].
The mechanisms involved in the development of filarial
lymphedema are not fully understood but they are known to be
a complex interaction between the parasite and the host’s immune
system [8,9].
Filarial lymphedema is painful and debilitating, accompanied
by skin changes, decreased joint range of motion and recurrent
infections. The presence of childhood filarial lymphedema results
in social problems including embarrassment, frequent absence
from school and even discontinuation of studies [10]. It is generally
accepted that acute dermatolymphangioadenitisis the main risk
factor for progression of lymphedema and incidence of these
attacks can be greatly reduced by the introduction of a basic ‘‘self
care’’ program consisting of daily limb washing, treatment of skin
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entry lesions, antibiotic treatment of established infections, gentle
exercise, appropriate footwear and limb elevation [11–13].
Although lymphoscintigraphy is an effective method for de-
tecting covert lymphatic changes, it is invasive in that it requires
the injection of a radioactive substance and is not suitable for use
in field-based research and the monitoring and evaluation, or ‘‘fine
tuning’’ of treatment programs for morbidity control.
This study was undertaken to establish a non-invasive method
to identify early, sub-clinical changes of lymphedema secondary to
LF in the lower limbs of adolescents in Papua New Guinea (PNG).
PNG was chosen because of the high Bancroftian filarial antigen
prevalence. There is a national plan for the elimination of LF but
PCT has only been started in two out of 19 provinces, and there is
currently no morbidity control component in place [2].
Methods
Ethics statement
Ethics approval was obtained from the PNG Medical Research
Advisory Council (MRAC number 08.25) and James Cook
University Human Ethics Committee, Townsville, Australia. The
proposed study was carefully explained to community leaders,
school teachers, and health care workers in English, Hiri Motu and
Tok Pisin. Parents provided verbal consent for their adolescents to
participate. In this community of low literacy the use of verbal
consent is appropriate and was approved by both the PNG
Medical Research Advisory Committee and James Cook Univer-
sity Human Ethics Committee.
Participants
The research was undertaken at Opau village, in central
Province whilst a baseline survey for the PNG national LF
program was conducted. Members of the village where inducted
into the study based on their willingness to participate after the
introduction (tok save). As adolescents (aged 10–21 years) were
inducted, their LF status was determined using the Binax ICT
rapid card test for filarial antigen [2] and demographic data was
collected. These individuals were divided into LF reactive and LF
non-reactive groups by the investigators responsible for sampling
and testing. Binax ICT testing was conducted according to the
manufacturers’ instructions. An age and sex matched sub-sample
of each group were selected for participation. Verbal consent was
sought and obtained from the parents of those inducted. The
researcher responsible for all measurements of the adolescents was
blinded to the results of the ICT test.
There are many methods available to assess the lymphatic
system. It was important that the methods included were inex-
pensive, portable and easy to apply in the field and therefore
usable in the context of PNG. Hence the following methods were
included in the study:
Circumferential measures of each lower limb were undertaken
using a tape measure following the protocol described by the
Australasian Lymphology Association [14]. This provided a gross
measure of limb size. Measurements were performed at the
metatarsophalangeal joints (MTP) (tape applied around the foot
from MTP 1 to MTP5), the foot adjacent to the leg (tape applied
around the dorsum and plantar aspect of the foot as close as
possible to the leg), and 10 and 15 centimetres above and below
the joint line of the knee. The distance from the knee was
measured with a rigid ruler from the medial and lateral joint lines
of the knee.
Tonometry was used to measure alterations in tissue resistance.
The tonometer consists of a plunger device which, when applied
to the skin, provides a measure of the ability of the skin and
underlying tissue to resist compression. A higher tonometry value
indicates greater indentation and decreased tissue resistance. It has
been used to investigate post-surgical lymphedema [15] and LF in
adults with established stage II and III lymphedema [16].
Tonometry was undertaken using a Flinders Tissue Tonometer
(Flinders Medical Centre Biomedical Engineering, Australia)
consisting of a central plunger operating through a 6 cm diameter
footplate that rests on the skin and applies a load of 200 grams.
The degree of penetration of the plunger is measured by a
micrometer on a linear scale [15]. The tonometer was calibrated
according to the manufacturers’ instructions prior to each mea-
surement session. The length of the posterior thigh was measured
from the gluteal fold to the posterior knee crease using a tape
measure. The value was halved and this mid-point in the centre of
the posterior thigh was marked. The same distance from the
superior aspect of the patella was marked on the anterior thigh.
The length of the calf was measured from the posterior knee crease
to the base of the heel. This value was halved and a point marked
on the centre of the posterior calf. The tonometer was placed on
the skin at each marked point and readings to the nearest
millimeter were recorded.
Goniometry was used to measure joint range of motion (ROM).
When lymphedema is present and limb size increases the range of
movement at joints can become restricted. Goniometry was
undertaken for ankle dorsiflexion, knee flexion and hip flexion of
each lower limb [17].
Bioimpedance spectroscopy (BIS) measures the opposition or
impedance (Z) to the flow of an alternating electrical current
passed through the body. The SFB7 used in this study performs
measurements at 256 frequencies over the range 3–1000 KHz.. At
low frequencies, ,20 kHz, the current passes predominantly
through the extra-cellular fluid (ECF) while at a high frequencies,
.50–100 kHz, it passes through both the intra- cellular fluid (ICF)
and the ECF. Thus the ratio of impedances, measured at high and
low frequencies, provides an indication of change in fluid dis-
tribution between the tissue compartments. In secondary lymph-
edema, increased volumes of ECF are expected and hence the
Author Summary
The effects of lymphatic filariasis (LF) on the lymphatic
system often become apparent during adolescence when
the lower limb swells due to lymphedema and males
develop hydrocele. Currently there is no simple or mobile
field method to identify those at greatest risk of
developing lymphedema or those with early subclinical
lower limb change. Fifty-three adolescents, 25 LF infected
and 28 LF non-infected were recruited to the study. The
groups were compared with respect to lower limb tissue
compressibility (tonometry), limb circumference (tape
measure), intra- and extra-cellular fluid distribution (bioim-
pedance) and hip, knee and ankle joint range of motion
(goniometry). Tonometry, is a simple, inexpensive tool,
which measures the distance a plunger will indent the soft
tissues. Those adolescents who were LF positive had
significantly increased soft tissue compressibility when
assessed with tonometry than adolescents who were LF
negative. Tonometry has high levels of sensitivity to
identify adolescents who test positive to LF. If we are able
to identify adolescents before they have overt symptoms,
management practices to decrease disease progression
can be implemented. This could prevent lifetime morbidity
and allow allocation of scarce resources to those identified
to be most at risk of developing lymphedema.
LF: Identifying Subclinical Lower Limb Change
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ratio of ICF to ECF should decrease. Since impedance is inversely
related to fluid volume this would be observed as an increase in the
impedance ratio Ri:Re (intracellular impedance: extracellular
impedance1).
Evidence exists that bioimpedance spectroscopy can identify a
change in fluid distribution in the arms of women at risk of
lymphedema following management for breast cancer up to six
months earlier than the usual clinical method of circumferential
measurement [18] . Bioimpedance instruments are light and
portable and may provide a more accessible and reasonable
method to identify early accumulation of fluid in the limbs of
adolescents.
Tissue bioimpedance was measured for each lower limb using
an Impedimed SFB7 bioimpedance spectrometer device (Impe-
diMed Limited, Unit 1–50 Parker Court, Pinkenba, Qld, 4008
Australia). Adhesive electrodes were attached to the feet and hands
of participants and the impedance recorded according to the
manufacturer’s instructions. All data was collected between the
hours of 11am and 3pm over three consecutive days. All mea-
surements were made with the subjects in the same position,
supine. There is no reason to anticipate that BIS will perform any
differently in a rural/village environment to elsewhere assuming a
consistent procedure is used. However, as no reliability studies
regarding the use of this equipment in a field environment were
available two bioimpedance measures were undertaken for each
limb. Bioimpedance values, goniometry and circumferential
measures are altered by limb composition hence participants were
asked which leg they would kick a ball with to determine limb
dominance.
Statistical analysis
Numerical variables were described using mean values and
standard deviations (SD) when found to be approximately
normally distributed. Median values and inter-quartile ranges
(IQR) were used when the variable was skewed. Participants with
and without lymphatic filariasis (LF) were compared using t-tests,
Fisher’s exact tests, and non-parametric Wilcoxon Mann-Whitney
test. Binary logistic regression analyses were conducted to identify
associations between lower limb measurements and LF. Demo-
graphic and body characteristics were considered as potential
confounders. The model was adjusted for a confounder when the
estimate changed by about 10% or more. Paired analyses com-
paring left and right limb were conducted using paired t-tests and
paired non-parametric Wilcoxon signed rank tests. Throughout
the analysis a significance level of 0.05 was assumed. Statistical
analysis was conducted using PASW (version 18 of SPSS; SPSS
Inc. IBM; Chicago; Illinois).
Results
In order to assess the reliability of the BIS measures we
calculated the concordance correlation coefficient by Lawrence I-
Kuei Lin [19]. The concordance correlation coefficient was high
with 0.88 (95%-confidence interval 0.82, 0.92) suggesting good
reliability of the measurement (Figure 1).
Mean age of the 53 participants was 16.5 years (SD 2.5; range
10 to 21 years) and 54.7% were female. Overall 47.2% tested
positive for LF. The mean weight of the participants was 50.6 kg
(SD 7.1) and the mean body mass index (BMI) was 19.7 kg/m2
(SD 1.9; range 14.5 to 23.6). Four participants (7.5%) were left leg
dominant and one participant (1.9%) would use both legs equally
to kick a ball (Table 1). None of the demographic and body
characteristics were significantly different for participants with and
without LF (Table 1).
The mean tonometric measurements from the left, right, and
dominant posterior thighs were significantly higher in participants
with LF compared to participants who had tested negative for LF
(p = 0.005, p= 0.004, and p=0.003, respectively; Table 2).
Logistic regression showed increasing the tonometric measure-
ment from the dominant posterior thigh by 1 unit increased the
odds of having tissue change secondary to LF by 2.2 (95%-
CI= (1.2, 4.1); p = 0.014). This result was adjusted for the
confounding effects of BMI.
The mean circumferential measurements of the right and
dominant thighs, 10 cm proximal to the knee, and of the left thigh,
15 cm proximal to the knee were significantly greater in par-
ticipants with LF compared to participants who had tested
negative for LF (p= 0.038, p = 0.042 and p= 0.043, respectively;
Table 2). However when adjusted for the confounding effects of
BMI those measurements were no longer significantly associated
with LF (p = 0.164, p= 0.189, p = 0.226, respectively).
There were no significant differences found in the impedance
ratio of the legs between LF positive and LF negative subjects,
irrespective of which leg was compared or of limb dominance
(Table 2). However there was a significant difference in the
bioimpedance ratios of the dominant and non-dominant legs of
the LF negative group. This relationship was not identified in the
LF positive group (Table 3) possibly suggesting that BIS is
detecting an LF-related change in ECW:ICW ratios but that this is
confounded by limb dominance effects upon the impedance
measurements.
These results support the use of tonometry of the dominant
posterior thigh to indentify alteration in tissue compressibility in
adolescents with sub-clinical lymphedema secondary to LF. Mean
and standard deviation values for dominant posterior thigh
tonometry in the positive LF group were 5.26 and 0.99 and in
the negative LF group were 4.38 and 1.07. Receiver operating
characteristics (ROC) curves were plotted to identify the optimal
cut-off for these measurements to differentiate between those with
and those without altered tissue compressibility related to LF.
Power when comparing tonometry of the dominant posterior thigh
in adolescents who are LF positive and LF negative was 86.3%.
ROC curve analysis to define optimal cut-off of the tonometry
measurements of the dominant posterior thigh to identify early
tissue changes is reported in Figure 2 and Table 4.
If we chose as the cut-off the 3.5, then sensitivity of this potential
screening test is 100% (95%-CI= 86.3%, 100%) and specificity is
21.4% (95%-CI= 8.3%, 41.0%). All true LF cases are detected as
such, but together with 22 false positive cases. The positive
predictive value is 53.2%. However the false positive cases could
be picked up in a second test.
Discussion
Digital tonometry identified increased tissue compressibility in
the posterior thigh in LF-infected adolescents with no overt signs
of secondary lymphedema. As there was no significant concom-
itant change in BIS values these findings indicate a softening of
tissue rather than altered intra- and extra-cellular fluid distribution
as the first measurable LF tissue changes. This is in contrast to
women who develop secondary lymphedema after breast cancer
(BC) where alteration of extra- and intra-cellular fluid distribution
is the earliest identifier of lymphatic change [18]. The difference in
1In BIS the impedances used for the low and high frequencies are those
determined at zero and infinite frequencies. At these frequencies, impedance and
electrical resistance (R) are identical and, by convention, are denoted by R rather
than Z.
LF: Identifying Subclinical Lower Limb Change
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sensitivity of measurement tools in the LF and BC groups is likely
to be related to the cause of lymphatic dysfunction. During
intervention for cancer the removal of lymph nodes and direct
trauma to the lymphatic tissue (surgical, radiation) are the main
contributors to secondary lymphedema. In LF, dilation of the
lymphatic vessels in response to the presence of the worm and the
host inflammatory response to the living worm and their secreted
antigens cause lymphatic damage [20]. Dilation of the lymphatics
in this early stage is unlikely to lead to the accumulation of lymph
seen in BC-related lymphedema and detected by BIS. Further,
when the worm dies symbiotic Wolbachia organisms are released
and introduce Wolbachia bacteria to the host which causes an
inflammatory response in the lymphatic system [8]. It has recently
been reported that living worms may also release bacteria and/or
the products of the symbiotic Wolbachia into their host [21]. A
study of Rhesus monkeys identified that they mount an antibody
response to Wolbachia surface proteins that are temporarily
associated with worm death and lymphedema development [8].
Specifically, increased Th1/Th17 responses and decreased regula-
tory T cells as well as regulation of Toll- and Nod-like receptors
have been identified in the pathogenesis of filarial lymphedema
[20]. Intra-subject between limb variation in BIS is expected due to
limb dominance and consequent variation in limb mass and
composition. This was not identified in the LF positive group.
Figure 1. Concordance correlation coefficient for repeated BIS measures.
doi:10.1371/journal.pntd.0001242.g001
Table 1. Demographics and body characteristics of participants stratified and compared by Lymphatic Filariasis (LF) status.
Characteristic Total n=53 LF negative n=28 LF positive n=25 p-value
Mean age (SD)* [years] 16.5 (2.5) 16.0 (2.6) 17.0 (2.3) P = 0.163
% Female 54.7% 46.4% 64.0% P= 0.271
Mean height (SD) [cm] 159.8 (6.7) 160 (7.1) 159.6 (6.3) P = 0.822
Mean weight (SD) [kg] 50.6 (7.1) 49.6 (6.1) 51.7 (8.0) P = 0.293
Mean BMI** (SD) [kg/m2] 19.7 (1.9) 19.3 (1.6) 20.2 (2.2) P = 0.111
% Dominant leg left or both 9.4% 7.1% 12.0% P= 0.658
*SD= standard deviation;
**BMI = body mass index.
doi:10.1371/journal.pntd.0001242.t001
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Table 2. Bioimpedance, range of motion, circumferential and tonometry measures for all participants and stratified for LF status.
Characteristic Total n=53 LF negative n=28 LF positive n=25 p-value
Tonometry (mm)
L mid-calf; mean (SD) 4.03 (0.90) 3.97 (0.99) 4.10 (0.81) P = 0.589
R mid-calf; mean (SD) 3.82 (0.81) 3.89 (0.74) 3.74 (0.89) P = 0.496
D mid-calf; mean (SD) 3.86 (0.78) 3.87 (0.71) 3.86 (0.86) P = 0.979
L posterior thigh; mean (SD) 4.59 (1.20) 4.17 (1.11) 5.07 (1.13) P = 0.005#
R posterior thigh; mean (SD) 4.80 (1.13) 4.39 (1.08) 5.26 (1.03) P = 0.004#
D posterior thigh; mean (SD) 4.80 (1.11) 4.38 (1.07) 5.26 (0.99) P = 0.003#
L anterior thigh; mean (SD) 5.31 (1.03) 5.13 (1.0) 5.5 (1.0) P = 0.190
R anterior thigh; median (IQR)** 5.43 (4.51, 5.96) 5.36 (4.35, 5.92) 5.52 (4.81, 6.05) P = 0.387
D anterior thigh; median (IQR) 5.45 (4.53, 6.00) 5.38 (4.37, 5.92) 5.60 (4.81, 6.05) P = 0.331
BIS ratio (Ri:Re)
R lower limb; mean (SD)* 2.58 (0.47) 2.56 (0.54) 2.59 (0.38) P = 0.798
L lower limb; mean (SD) 2.62 (0.47) 2.64 (0.51) 2.59 (0.43) P = 0.703
D lower limb; mean (SD) 2.57 (0.47) 2.55 (0.54) 2.59 (0.38) P = 0.743
Goniometry (degrees)
R ankle dorsi-flexion ROM; mean (SD) 7.5 (3.0) 7.5 (2.7) 7.4 (3.5) P = 0.944
L ankle dorsi-flexion ROM; mean (SD) 7.2 (3.3) 7.0 (3.0) 7.3 (3.7) P = 0.731
D ankle dorsi-flexion ROM; mean (SD) 7.4 (3.2) 7.6 (2.7) 7.3 (3.6) P = 0.791
R knee flexion ROM; mean (SD) 144.7 (4.1) 144.4 (5.1) 145.0 (2.7) P = 0.570
L knee flexion ROM; mean (SD) 144.8 (6.8) 144.8 (6.3) 144.8 (7.4) P = 0.992
D knee flexion ROM; mean (SD) 144.7 (3.9) 144.4 (4.8) 145.0 (2.8) P = 0.630
R hip flexion ROM; mean (SD) 103.9 (8.1) 104.8 (9.3) 103.0 (6.7) P = 0.417
L hip flexion ROM; mean (SD) 104.6 (7.9) 104.3 (7.2) 104.9 (8.7) P = 0.785
D hip flexion ROM; mean (SD) 104.2 (8.0) 104.9 (9.2) 103.3 (6.5) P = 0.470
Circumferential measures (cm)
L MTP; mean (SD) 23.0 (1.5) 23.1 (1.5) 22.9 (1.5) P = 0.606
R MTP; mean (SD) 23.0 (1.5) 23.0 (1.3) 22.9 (1.6) P = 0.940
D MTP; mean (SD) 23.0 (1.4) 23.0 (1.3) 22.9 (1.6) P = 0.877
L dorsum; mean (SD) 24.8 (1.8) 25.0 (2.0) 24.5 (1.6) P = 0.394
R dorsum; mean (SD) 24.6 (1.6) 24.5 (1.5) 24.6 (1.6) P = 0.837
D dorsum; mean (SD) 24.6 (1.5) 24.6 (1.5) 24.6 (1.6) P = 0.904
L 10 cm proximal; mean (SD) 36.7 (2.8) 36.0 (2.0) 37.4 (3.4) P = 0.063
R 10 cm proximal; mean (SD) 36.9 (2.9) 36.1 (2.0) 37.8 (3.4) P = 0.038#
D 10 cm proximal; mean (SD) 36.9 (2.9) 36.1 (2.0) 37.7 (3.4) P = 0.042#
L 10 cm distal; mean (SD) 30.8 (1.9) 30.5 (1.5) 31.2 (2.3) P = 0.172
R 10 cm distal; mean (SD) 30.8 (2.0) 30.5 (1.5) 31.2 (2.4) P = 0.174
D 10 cm distal; mean (SD) 30.8 (2.0) 30.5 (1.5) 31.2 (2.4) P = 0.180
L 15 cm proximal; mean (SD) 40.8 (3.1) 40.0 (2.5) 41.7 (3.5) P = 0.043#
R 15 cm proximal; mean (SD) 40.8 (4.0) 40.4 (2.3) 41.3 (5.4) P = 0.410
D15 cm proximal; mean (SD) 40.8 (4.0) 40.4 (2.3) 41.3 (5.3) P = 0.445
L 15 cm distal; mean (SD) 30.8 (3.0) 31.1 (3.1) 30.5 (2.9) P = 0.462
R 15 cm distal; mean (SD) 30.9 (2.6) 30.8 (2.7) 31.0 (2.6) P = 0.722
D 15 cm distal; mean (SD) 30.9 (2.6) 30.8 (2.7) 31.0 (2.6) P = 0.786
*SD= standard deviation;
**IQR = inter-quartile range;
#= significant p-value.
right limb (R), left limb (L) and dominant limb (D).
doi:10.1371/journal.pntd.0001242.t002
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Table 3. Bioimpedance, range of motion, circumferential and tonometry measures comparing dominant with non-dominant
limbs.
Characteristic Total n=53 LF negative n=28 LF positive n=25
BIS ratio (Ri:Re)
Lower limb; mean (SD)* P = 0.112 P = 0.003# P= 0.935
Goniometry (degrees)
Ankle dorsi-flexion; mean (SD) P = 0.462 P = 0.159 P = 0.841
Knee flexion; mean (SD) P = 0.869 P = 0.740 P = 0.981
Hip flexion; mean (SD) P = 0.928 P = 0.532 P = 0.404
Circumferential measures (cm)
MTP; mean (SD) P = 0.518 P = 0.512 P = 0.899
Dorsum; mean (SD) P = 0.362 P = 0.285 P = 0.720
10 cm proximal; mean (SD) P = 0.132 P = 0.342 P = 0.250
10 cm distal; mean (SD) P = 0.851 P = 0.926 P = 0.862
15 cm proximal; mean (SD) P = 0.983 P = 0.231 P = 0.577
15 cm distal; mean (SD) P = 0.826 P = 0.666 P = 0.282
Tonometry (mm)
Mid-calf; mean (SD) P = 0.277 P = 0.396 P = 0.501
Posterior thigh; mean (SD) P = 0.132 P = 0.265 P = 0.325
Anterior thigh; mean (SD) P = 0.426 P = 0.829 P = 0.367
*SD= standard deviation;
#= significant p-value.
doi:10.1371/journal.pntd.0001242.t003
Figure 2. Receiver Operating Characteristic (ROC) curve for tonometry measurement of tissue compressibility of the dominant
posterior thigh.
doi:10.1371/journal.pntd.0001242.g002
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Research is required to determine if increased tissue compress-
ibility is due to fatty infiltration, collagen breakdown, loosening of
inter-cellular junctions or simply dilation of lymph vessels.
Two sets of genetic risk factors have been suggested for the
development of lymphedema, immune response genes associated
with heightened inflammatory responses and lymphatic damage
following filarial infection and genes associated with impaired
lymphangiogenesis [8].
Thigh measures are likely to show the earliest change due to the
heavy worm burden in the groin associated with LF. In adult
males the worms have been identified by ultrasound to have a
preference for the vessels associated with the spermatic cord [22]
while in young boys they are found in the inguinal or other
peripheral lymph nodes [8] and in the scrotal lymphatic vessels
[23]. It has been suggested therefore that puberty and hormonal
change may alter worm infestation. This may have contributed to
why BIS did not detect differences in this study. The electrode
placement in this study measured the impedance of the whole
lower limb. As impedance is inversely proportional to the cross
sectional area of the limb this results in the impedance of the whole
leg being dominated by that of the smaller cross-sectional area of
the lower leg, calf and below. Therefore even if impedance of the
thigh is different the sensitivity to detect this difference is decreased
when measuring the whole leg. BIS sensitivity should be improved
by altering electrode placement and measuring the thigh region
only.
Tonometry is simple to learn, non-invasive, portable, does not
require electricity or batteries and is relatively inexpensive
(,$500AUD). After a short training session (30 minutes), subse-
quent practice and establishment of intra-measurer reliability it
would be suitable for use by community health workers. The
training session should include the manufacturers requirements for
calibration of the tonometer on a flat surface prior to
measurement, placement of the tonometer in contact with the
skin surface to be measured in a vertical position and reading of
the measurement dial. As each measurement takes less than a
minute one tonometer would allow a large number of people to be
assessed. Tonometry could be used to screen for onset of tissue
change, to monitor tissue change and the effect of interventions in
those with established lymphedema. A digital tonometer is being
developed that may allow even easier field use.
Tonometry is most reliable when assessed on an even surface.
This may account for the difference in findings for the posterior
and anterior thigh tonometry measures as when lying in the prone
position the posterior thigh provides a more even surface than the
anterior thigh in the supine position. There are many factors
which contribute to the development of lymphatic change in the
LF population, many of which are not well understood. It is not
known if all the positive LF adolescents identified in this study will
undergo progressive lymphatic change.. Further research is
required to track changes in tonometry, circumferential measures
and BIS in these participants and better understand the
progression of lymphatic and tissue change related to LF.
This study suggests possible cut-off values for tonometry which
may indicate tissue change characteristic of LF in an at-risk
population of PNG adolescents. However, this should not be
generalized to other populations and requires further research to
establish its generalisability even within PNG. The cut-off chosen
in this analysis results in low specificity and a high number of false
positives. However the consequences of being wrongly treated are
little in comparison to unidentified and unmanaged lymphedema.
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